Holen Sie sich die Stockscreener-App
4.83
2.55%
0.12
Handel nachbörslich:
4.82
-0.010
-0.21%
Schlusskurs vom Vortag:
$4.71
Offen:
$4.71
24-Stunden-Volumen:
64,822
Relative Volume:
0.21
Marktkapitalisierung:
$226.25M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.62%
1M Leistung:
-14.89%
6M Leistung:
+18.67%
1J Leistung:
+0.00%
1-Tages-Spanne:
$4.62
$4.85
1-Wochen-Bereich:
$4.55
$5.17
52-Wochen-Spanne:
$3.4341
$15.37
Capsovision Inc Stock (CV) Company Profile
Firmenname
Capsovision Inc
Sektor
Branche
Telefon
(408) 370-4790
Adresse
18805 COX AVENUE SUITE 250, SARATOGA
Compare CV vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CV
Capsovision Inc
|
4.83 | 220.63M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Capsovision Inc Stock (CV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-28 | Eingeleitet | Roth Capital | Buy |
| 2025-07-28 | Eingeleitet | The Benchmark Company | Speculative Buy |
Capsovision Inc Aktie (CV) Neueste Nachrichten
Short Interest in CapsoVision, Inc. (NASDAQ:CV) Increases By 281.0% - MarketBeat
CapsoVision prices $27.5M IPO - MSN
Short Interest in CapsoVision, Inc. (NASDAQ:CV) Declines By 57.4% - MarketBeat
Reviewing Perspective Therapeutics (NASDAQ:CATX) & CapsoVision (NASDAQ:CV) - Defense World
CapsoVision seeks FDA clearance for AI endoscopy module - MSN
CapsoVision (CV) Price Target Increased by 75.00% to 10.71 - Nasdaq
CapsoVision (NASDAQ:CV) Upgraded by Wall Street Zen to “Hold” Rating - Defense World
CapsoVision Submits 510(k) Application for CapsoCam AI-Assisted Module - Medical Product Outsourcing
CapsoVision price target raised to $14 from $5 at Benchmark - MSN
CapsoVision submits FDA 510(k) for AI-assisted module in CapsoCam Plus - MSN
US Smart Pills Market to Reach US$ 619.10 Million by 2033 | CAGR - openPR.com
CapsoVision Submits FDA 510(k) for AI-Assisted Module in CapsoCam Plus - Barchart.com
CapsoVision (NASDAQ:CV) Shares Gap DownHere's Why - MarketBeat
CapsoVision, Inc.'s (NASDAQ:CV) Path To Profitability - 富途牛牛
CapsoVision Shares Rise After Company Files 510(k) With US FDA to Add AI-Assisted Module to CapsoCam Plus - MarketScreener
CapsoVision (NASDAQ:CV) Shares Gap UpHere's What Happened - MarketBeat
CapsoVision, ACM Research And Other Big Stocks Moving Higher On Tuesday - Benzinga
CapsoVision Stock Pre-Market (-11%) : FDA 510(k) Submission for AI Module - Trefis
Verastem, TEN Holdings And 3 Stocks To Watch Heading Into Tuesday - Benzinga
CapsoVision submits FDA application for AI-assisted capsule endoscopy By Investing.com - Investing.com Nigeria
CapsoVision submits FDA application for AI-assisted capsule endoscopy - Investing.com
CapsoVision Seeks FDA Clearance for AI Endoscopy Module - TipRanks
CapsoVision Files 510(k) With US FDA to Add AI-Assisted Module to CapsoCam Plus - MarketScreener
CapsoVision Announces 510(k) Submission for the Addition of AI-Assisted Reading Module in CapsoCam Plus® - The Manila Times
CapsoVision, Inc Submits 510(k) Application for AI Module - TradingView — Track All Markets
Certain Common Stock of CapsoVision, Inc. are subject to a Lock-Up Agreement Ending on 29-DEC-2025. - MarketScreener
Certain Stock Options of CapsoVision, Inc. are subject to a Lock-Up Agreement Ending on 29-DEC-2025. - MarketScreener
Certain Warrants of CapsoVision, Inc. are subject to a Lock-Up Agreement Ending on 29-DEC-2025. - MarketScreener
CapsoVision (NASDAQ:CV) Shares Down 6.5% – Time to Sell? - Defense World
CapsoVision, Inc. (NASDAQ:CV) Short Interest Up 171.0% in December - MarketBeat
CapsoVision (NASDAQ:CV) Trading Down 6.5%Here's Why - MarketBeat
CapsoVision (NASDAQ:CV) Trading Up 12.9%Here's Why - MarketBeat
Honeywell, Intuitive Machines And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Sahm
Sidus Space, Starfighters Space And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Sahm
CapsoVision, Inc.’s Lock-Up Period Set To End on December 29th (NASDAQ:CV) - Defense World
CapsoVision Inc Trading Resumes - MSN
CapsoVision (NASDAQ:CV) Trading Down 3.1%Time to Sell? - MarketBeat
CapsoVision (NASDAQ:CV) Trading Up 7.3%Here's Why - MarketBeat
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Return on assets % of CapsoVision, Inc. – DUS:H6U - TradingView — Track All Markets
CapsoVision (NASDAQ:CV) Trading Down 15%Here's Why - MarketBeat
CapsoVision Announces Leadership Transition Plans - MSN
Broadcom, LightPath Technologies, Netskope And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Sahm
CapsoVision Stock Surges 161%, With A 7-Day Winning Spree - Trefis
CapsoVision (NASDAQ:CV) Hits New 1-Year HighHere's Why - MarketBeat
ETFs Investing in CapsoVision, Inc. Stocks - TradingView — Track All Markets
CapsoVision (NASDAQ: CV) Stock Rockets After-Hours: Price Action, Q3 Earnings and 2026 Outlook - ts2.tech
Oxford Industries, Ur-Energy, Oracle And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
Is CapsoVision Showing How Far A Single Capsule Can Take A Med-Tech Company? - RTTNews
CapsoVision Stock Rockets 114% With 6-Day Winning Streak - Trefis
What Sparked CapsoVision's (CV) 53% Surge In After-Hours Trading? - Sahm
Finanzdaten der Capsovision Inc-Aktie (CV)
Es liegen keine Finanzdaten für Capsovision Inc (CV) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Capsovision Inc-Aktie (CV) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| GOUW JULIA S | Director |
Dec 31 '25 |
Option Exercise |
10.69 |
2,887 |
30,862 |
2,887 |
| Imperial Joanne Carol | Director |
Dec 31 '25 |
Option Exercise |
10.69 |
2,887 |
30,862 |
2,887 |
| King Wen-Herng Henry | Director |
Dec 31 '25 |
Option Exercise |
10.69 |
2,887 |
30,862 |
23,597 |
| Kuo Hui Ying | Director |
Dec 31 '25 |
Option Exercise |
10.69 |
2,887 |
30,862 |
13,241 |
| Tsai Chen Lung | Director |
Dec 31 '25 |
Option Exercise |
10.69 |
2,887 |
30,862 |
2,887 |
| Petersen Rebecca Ann | Director of Clinical Affairs |
Aug 18 '25 |
Option Exercise |
0.37 |
24,834 |
9,097 |
24,834 |
1.33%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):